These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 2480464

  • 1. [Potentiating effect of secretin on cholecystokinin-stimulated exocrine pancreatic secretion in rats].
    Moriyoshi Y.
    Nihon Shokakibyo Gakkai Zasshi; 1989 Oct; 86(10):2425-33. PubMed ID: 2480464
    [Abstract] [Full Text] [Related]

  • 2. Potentiating effect of CCK and secretin on rat exocrine pancreas and its cholinergic dependence.
    Moriyoshi Y, Shiratori K, Watanabe S, Takeuchi T.
    Pancreas; 1991 Sep; 6(5):603-8. PubMed ID: 1719526
    [Abstract] [Full Text] [Related]

  • 3. Role of secretin and cholecystokinin in oleic acid-stimulated pancreatic secretion in rats.
    Shiratori K, Watanabe S, Takeuchi T, Shimizu K, Moriyoshi Y.
    Gastroenterol Jpn; 1990 Feb; 25(1):104-11. PubMed ID: 1689684
    [Abstract] [Full Text] [Related]

  • 4. Somatostatin analog, SMS 201-995, inhibits pancreatic exocrine secretion and release of secretin and cholecystokinin in rats.
    Shiratori K, Watanabe S, Takeuchi T.
    Pancreas; 1991 Jan; 6(1):23-30. PubMed ID: 1704631
    [Abstract] [Full Text] [Related]

  • 5. [Inhibitory effect of CR 1409 (cholecystokinin antagonist) on pancreatic exocrine secretion in rats].
    Shiratori K, Watanabe S, Shimizu K, Moriyoshi Y, Chang JH, Takeuchi T.
    Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):70-6. PubMed ID: 2471850
    [Abstract] [Full Text] [Related]

  • 6. [Effect of intraduodenal oligopeptide on rat pancreatic exocrine secretion and release of secretin and CCK].
    Shimizu K.
    Nihon Shokakibyo Gakkai Zasshi; 1990 Nov; 87(11):2509-16. PubMed ID: 1703583
    [Abstract] [Full Text] [Related]

  • 7. Endogenous nitric oxide mediates pancreatic exocrine secretion stimulated by secretin and cholecystokinin in rats.
    Jyotheeswaran S, Li P, Chang TM, Chey WY.
    Pancreas; 2000 May; 20(4):401-7. PubMed ID: 10824696
    [Abstract] [Full Text] [Related]

  • 8. Potentiating effect of secretin on cholecystokinin-stimulated pancreatic secretion in dogs.
    Chey WY, Lee KY, Chang TM, Chen YF, Millikan L.
    Am J Physiol; 1984 Mar; 246(3 Pt 1):G248-52. PubMed ID: 6322594
    [Abstract] [Full Text] [Related]

  • 9. Effect of CCK antagonists CR 1409 and CR 1505 on rat pancreatic exocrine secretion in vivo.
    Shiratori K, Shimizu K, Watanabe S, Takeuchi T, Moriyoshi Y.
    Pancreas; 1989 Mar; 4(6):744-50. PubMed ID: 2813333
    [Abstract] [Full Text] [Related]

  • 10. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K, Saito T, Wakatsuki K, Saeki M, Kato T, Kasai H, Kimura K, Fujii M.
    Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
    [Abstract] [Full Text] [Related]

  • 11. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
    Gabryelewicz A, Kulesza E, Konturek SJ.
    Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
    [Abstract] [Full Text] [Related]

  • 12. Hormonal mechanism of sodium oleate-stimulated pancreatic secretion in rats.
    Li P, Lee KY, Chang TM, Chey WY.
    Am J Physiol; 1990 Dec; 259(6 Pt 1):G960-5. PubMed ID: 2260665
    [Abstract] [Full Text] [Related]

  • 13. Role of cholecystokinin in pancreatic bicarbonate secretion in dogs.
    Jo YH, Lee KY, Chang TM, Chey WY.
    Pancreas; 1991 Mar; 6(2):197-201. PubMed ID: 1886888
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.
    Cantor P, Olsen O, Gertz BJ, Gjorup I, Worning H.
    Scand J Gastroenterol; 1991 Jun; 26(6):627-37. PubMed ID: 1713709
    [Abstract] [Full Text] [Related]

  • 15. Effect of acute hyperglycemia on basal, secretin and secretin + cholecystokinin stimulated exocrine pancreatic secretion in humans.
    Lam WF, Masclee AA, Souverijn JH, Lamers CB.
    Life Sci; 1999 Jun; 64(8):617-26. PubMed ID: 10069525
    [Abstract] [Full Text] [Related]

  • 16. PYY potently inhibits pancreatic exocrine secretion mediated through CCK-secretin-stimulated pathways but not 2-DG-stimulated pathways in awake rats.
    Deng X, Guarita DR, Wood PG, Kriess C, Whitcomb DC.
    Dig Dis Sci; 2001 Jan; 46(1):156-65. PubMed ID: 11270780
    [Abstract] [Full Text] [Related]

  • 17. Atropine abolishes the potentiation effect of secretin and cholecystokinin-octapeptide on exocrine pancreatic secretion in humans.
    You CH, Chey WY.
    Pancreas; 1988 Jan; 3(1):99-103. PubMed ID: 3362847
    [Abstract] [Full Text] [Related]

  • 18. Potentiation of cholecystokinin and secretin-induced pancreatic exocrine secretion by endogenous insulin in humans.
    Kim C, Kim K, Lee H, Song C, Ryu H, Hyun J.
    Pancreas; 1999 May; 18(4):410-4. PubMed ID: 10231848
    [Abstract] [Full Text] [Related]

  • 19. Role of CCK-A receptor in the regulation of pancreatic bicarbonate secretion in conscious rats: a study in naturally occurring CCK-A receptor gene knockout rats.
    Miyasaka K, Suzuki S, Kanai S, Masuda M, Funakoshi A.
    Pancreas; 1999 Oct; 19(3):217-23. PubMed ID: 10505751
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.